Manufacturer of Controlled Substances; Notice of Registration, 76756-76757 [2010-30899]

Download as PDF 76756 Federal Register / Vol. 75, No. 236 / Thursday, December 9, 2010 / Notices of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: November 29, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: November 29, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–30897 Filed 12–8–10; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2010–30904 Filed 12–8–10; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Registration Drug Enforcement Administration By Notice dated July 19, 2010, and published in the Federal Register on July 28, 2010, (75 FR 44285), Johnson Matthey Pharmaceutical Materials, Inc., Pharmaceuticals Service, 25 Patton Road, Devens, Massachusetts 01434, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances: Drug Manufacturer of Controlled Substances; Notice of Registration By Notice dated March 16, 2010, and published in the Federal Register on March 24, 2010, (75 FR 14189), Norac Inc., 405 S. Motor Avenue, P.O. Box 577, Azusa, California 91702–3232, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances: Schedule Drug erowe on DSK5CLS3C1PROD with NOTICES Amphetamine (1100) .................... Methylphenidate (1724) ................ Nabilone (7379) ............................ Alfentanil (9737) ........................... Sufentanil (9740) .......................... Remifentanil (9739) ...................... Hydrocodone (9193) ..................... II II II II II II II Gamma Hydroxybutyric Acid (2010). Tetrahydrocannabinols (7370) ..... Methamphetamine (1105) ............ Nabilone (7379) ............................ The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk and to conduct analytical testing in support of the company’s primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to the company’s customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Pharmaceutical Materials, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey Pharmaceutical Materials, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included VerDate Mar<15>2010 15:35 Dec 08, 2010 Jkt 223001 Schedule I I II II With regard to Gamma Hydroxybutyric Acid (2010), Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the company manufactures these controlled substances in bulk solely for domestic distribution within the United States to customers engaged in dosage-form manufacturing. With regard to Nabilone (7379) only, the company presently manufactures a small amount of this controlled substance in bulk solely to conduct manufacturing process development internally within the company. It is the company’s intention that, when the manufacturing process is refined to the point that its Nabilone bulk product is available for commercial use, the company will export the controlled substance in bulk solely to customers engaged in dosage-form manufacturing outside the United States. The company is aware of the requirement to obtain a PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 DEA registration as an exporter to conduct this activity. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Norac, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Norac, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: November 29, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–30903 Filed 12–8–10; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated July 23, 2010, and published in the Federal Register on August 4, 2010, (75 FR 47029), Johnson Matthey Pharma Services, 70 Flagship Drive, North Andover, Massachusetts 01845, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances: Drug Amphetamine (1100) .................... Methylphenidate (1724) ................ Hydrocodone (9193) ..................... Schedule II II II The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk and to conduct analytical testing in support of the company’s primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to the company’s customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and E:\FR\FM\09DEN1.SGM 09DEN1 Federal Register / Vol. 75, No. 236 / Thursday, December 9, 2010 / Notices determined that the registration of Johnson Matthey Pharma Services to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey Pharma Services to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: November 29, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–30899 Filed 12–8–10; 8:45 am] BILLING CODE 4410–09–P NATIONAL SCIENCE FOUNDATION National Science Board; Sunshine Act Meetings; Notice The National Science Board’s Subcommittee on Facilities, pursuant to NSF regulations (45 CFR Part 614), the National Science Foundation Act, as amended (42 U.S.C. 1862n–5), and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice in regard to the scheduling of a meeting for the transaction of National Science Board business and other matters specified, as follows: DATE: December 15, 2010. 11 a.m. to 12:30 p.m. • NSF Principles & Portfolio Review • Future Budgetary Issues FY 2012 and beyond TIME AND SUBJECT MATTER OPEN: STATUS: Closed. The closed session of this teleconference will be held at the National Science Foundation, 4201 Wilson Blvd., Arlington, VA 22230. LOCATION: Please refer to the National Science Board Web site https://www.nsf.gov/nsb for additional information and schedule updates (time, place, subject matter or status of meeting) may be found at https://www.nsf.gov/nsb/notices/. Point of contact for this meeting is: Jennie Moehlmann, National Science Board erowe on DSK5CLS3C1PROD with NOTICES UPDATES AND POINT OF CONTACT: VerDate Mar<15>2010 15:35 Dec 08, 2010 Jkt 223001 Office, 4201 Wilson Blvd., Arlington, VA 22230. Telephone: (703) 292–7000. Daniel A. Lauretano, Counsel to the National Science Board. [FR Doc. 2010–31067 Filed 12–7–10; 4:15 pm] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION [Docket Nos. 50–498, 50–499; NRC–2010– 0375] STP Nuclear Operating Company; Notice of Receipt and Availability of Application for Renewal of South Texas Project, Units 1 and 2; Facility Operating License Nos. NPF–76 and NPF–80 for an Additional 20-Year Period The U.S. Nuclear Regulatory Commission (NRC or Commission) has received an application, dated October 25, 2010, from STP Nuclear Operating Company, filed pursuant to Section 103 of the Atomic Energy Act of 1954, as amended, and Title 10 of the Code of Federal Regulations part 54 (10 CFR part 54), to renew the operating licenses for the South Texas Project (STP), Units 1 and 2. Renewal of the licenses would authorize the applicant to operate each facility for an additional 20-year period beyond the period specified in the respective current operating licenses. The current operating license for STP Unit 1 (NPF–76) expires on August 20, 2027. STP Unit 1 is a pressurized water reactor designed by Westinghouse. The current operating license for STP Unit 2 expires on December 15, 2028. STP Unit 2 is a pressurized water reactor designed by Westinghouse. Both units are located 12 miles south southwest of Bay City, TX. The acceptability of the tendered application for docketing, and other matters including an opportunity to request a hearing, will be the subject of subsequent Federal Register notices. Copies of the application are available to the public at the Commission’s Public Document Room (PDR), located at One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852 or through the Internet from the NRC’s Agencywide Documents Access and Management System (ADAMS) Public Electronic Reading Room under Accession Number ML103010256. The ADAMS Public Electronic Reading Room is accessible from the NRC Web site at https://www.nrc.gov/reading-rm/ adams.html. In addition, the application is available at https://www.nrc.gov/ reactors/operating/licensing/renewal/ applications.html. Persons who do not have access to the Internet or who PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 76757 encounter problems in accessing the documents located in ADAMS should contact the NRC’s PDR reference staff at 1–800–397–4209, extension 4737, or by e-mail to pdr@nrc.gov. A copy of the license renewal application for the STP, Units 1 and 2, is also available to local residents near the site at the Bay City Public Library, 1100 7th Street, Bay City, TX 77414. Dated at Rockville, Maryland, this 23rd day of November, 2010. For the Nuclear Regulatory Commission. A. Louise Lund, Acting Deputy Director, Division of License Renewal, Office of Nuclear Reactor Regulation. [FR Doc. 2010–30956 Filed 12–8–10; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Licensing Support System Advisory Review Panel U.S. Nuclear Regulatory Commission. ACTION: Notice of renewal of the Charter of the Licensing Support Network Advisory Review Panel (LSNARP). AGENCY: The Licensing Support System Advisory Review Panel was established by the U.S. Nuclear Regulatory Commission as a Federal Advisory Committee in 1989. Its purpose was to provide advice on the fundamental issues of design and development of an electronic information management system to be used to store and retrieve documents relating to the licensing of a geologic repository for the disposal of high-level radioactive waste, and on the operation and maintenance of the system. This electronic information management system was known as the Licensing Support System (LSS). In November, 1998 the Commission approved amendments to 10 CFR part 2 that renamed the Licensing Support System Advisory Review Panel as the Licensing Support Network Advisory Review Panel. The Licensing Support Network (LSN) in use since 2004 and now contains over 4 million documents associated the proposed high-level waste facility. Membership on the Panel will continue to be drawn from those interests that will be affected by the use of the LSN, including the Department of Energy, the NRC, the State of Nevada, the National Congress of American Indians, affected units of local governments in Nevada, the Nevada Nuclear Waste Task Force, and a SUMMARY: E:\FR\FM\09DEN1.SGM 09DEN1

Agencies

[Federal Register Volume 75, Number 236 (Thursday, December 9, 2010)]
[Notices]
[Pages 76756-76757]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-30899]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated July 23, 2010, and published in the Federal 
Register on August 4, 2010, (75 FR 47029), Johnson Matthey Pharma 
Services, 70 Flagship Drive, North Andover, Massachusetts 01845, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Hydrocodone (9193).........................  II
------------------------------------------------------------------------

    The company plans to utilize this facility to manufacture small 
quantities of the listed controlled substances in bulk and to conduct 
analytical testing in support of the company's primary manufacturing 
facility in West Deptford, New Jersey. The controlled substances 
manufactured in bulk at this facility will be distributed to the 
company's customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and

[[Page 76757]]

determined that the registration of Johnson Matthey Pharma Services to 
manufacture the listed basic classes of controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Johnson Matthey Pharma Services to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, 
the above named company is granted registration as a bulk manufacturer 
of the basic classes of controlled substances listed.

    Dated: November 29, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-30899 Filed 12-8-10; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.